Yujiro Hata
Founder presso IDEAYA BIOSCIENCES, INC.
Patrimonio netto: 30 M $ in data 31/03/2024
Profilo
Yujiro S.
Hata is the founder of IDEAYA Biosciences, Inc. founded in 2015, where he holds the position of President, Chief Executive Officer & Director.
He currently holds positions as Director at Experimed Bioscience, Inc. and Director-Moores Cancer Center at the University of California San Diego, as well as Independent Director at Enanta Pharmaceuticals, Inc. since 2021.
Mr. Hata's education history includes an undergraduate degree from the University of Oxford, an undergraduate degree from The Colorado College, and an MBA from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
IDEAYA BIOSCIENCES, INC.
0.91% | 01/03/2024 | 677 887 ( 0.91% ) | 30 M $ | 31/03/2024 |
XENCOR, INC.
-.--% | 28/02/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
| 06/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Yujiro Hata
| Società | Posizione | Inizio |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Founder | 01/06/2015 |
| ENANTA PHARMACEUTICALS, INC. | Director/Board Member | 19/08/2021 |
Experimed Bioscience, Inc.
 Experimed Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Experimed Bioscience, Inc. engages in research and development of drugs. The company was founded by Schepartz Alanna and is headquartered in South San Francisco, CA | Director/Board Member | - |
| University of California San Diego | Corporate Officer/Principal | - |
Precedenti posizioni note di Yujiro Hata
| Società | Posizione | Fine |
|---|---|---|
| XENCOR, INC. | Director/Board Member | 08/09/2022 |
| RAPT THERAPEUTICS, INC. | Chief Operating Officer | 01/08/2015 |
Flexus Biosciences, Inc.
 Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA. | Chief Operating Officer | 30/04/2015 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/10/2013 |
| ENANTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2010 |
Formazione di Yujiro Hata
| University of Oxford | Undergraduate Degree |
| The Colorado College | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| XENCOR, INC. | Health Technology |
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| RAPT THERAPEUTICS, INC. | Health Technology |
| IDEAYA BIOSCIENCES, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Experimed Bioscience, Inc.
Experimed Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Experimed Bioscience, Inc. engages in research and development of drugs. The company was founded by Schepartz Alanna and is headquartered in South San Francisco, CA | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Flexus Biosciences, Inc.
Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA. | Health Technology |
Expansion Therapeutics, Inc.
 Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | Health Technology |
- Borsa valori
- Insiders
- Yujiro Hata
